Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Avidity Biosciences is a pioneering biopharmaceutical company at the forefront of oligonucleotide therapeutics, specializing in the development of Antibody Oligonucleotide Conjugates (AOCs). Operating within the biotechnology and pharmaceutical sectors, Avidity is focused on creating targeted RNA therapies for serious diseases, particularly muscular dystrophies, where existing treatments are inadequate. Leveraging its proprietary AOC platform, Avidity is establishing itself as a leader in precision medicine, aiming to address previously untreatable or difficult-to-treat conditions and carve out a significant market share in the rapidly evolving oligonucleotide therapeutics landscape.
Department | HeadCount |
---|---|
Administrative | 15 |
Consulting | 2 |
Service | 3 |
Design | 0 |
Education | 0 |
Finance | 12 |
Management | 18 |
Hr | 7 |
Legal | 13 |
Marketing | 8 |
Medical | 22 |
Operations | 30 |
Department | 75 |
Product | 1 |
Management | 6 |
Estate | 0 |
Research | 90 |
Sales | 7 |
Technical | 3 |
Trades | 0 |
Avidity Biosciences' department distribution strongly emphasizes Research and Development (R&D), indicative of a company deeply invested in innovation and early-stage drug development. The substantial R&D workforce, comprising the Research department and a sizable 'Other Departments' segment likely involved in related activities like pre-clinical studies and formulation development, underscores their commitment to scientific discovery. A significant Operations department signals a growing focus on scaling up manufacturing processes for clinical trials and potential commercialization. The relatively smaller Sales and Marketing teams suggest that Avidity is currently prioritizing clinical development and regulatory approvals over aggressive market penetration, which is typical for a company in the clinical stages of drug development. The Medical Affairs team's size reflects the need for strong clinical trial management and engagement with regulatory agencies. The Legal and HR departments provide crucial support in navigating the complex regulatory environment and attracting and retaining top scientific talent, respectively. Overall, the departmental structure reflects a biotech firm heavily invested in the discovery, development, and clinical validation of its novel AOC therapies, with a strategic eye towards future commercial scalability.
Total: 311 employees
Avidity Biosciences exhibits a predominantly domestic workforce, with the vast majority of its employees based in the United States. This concentration reflects the company's origins, core research facilities, and primary focus on the US market for initial clinical development and regulatory pathways. The limited international presence, with small teams in Europe (Germany, Switzerland, United Kingdom, Italy), India, and Canada, suggests a strategic approach to support ongoing or planned clinical trials and potential future market access in key regions. The European presence is likely driven by access to skilled scientific talent and established healthcare systems. The presence in Canada and India may support specific R&D or administrative functions, leveraging cost efficiencies or specialized expertise. Overall, Avidity's geographic distribution indicates a primarily US-centric operation, with a deliberate and measured approach to international expansion tailored to support its clinical development pipeline and future commercialization goals. This strategy allows the company to maintain tight control over its core operations while selectively tapping into global resources and markets as needed.
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early